Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

General/Other

    • Home
    • General/Other
General/Other

Leadership Shuffle at China’s National Health Commission: Liu Jinfeng Steps in as Deputy Director

Fineline Cube Sep 13, 2024

The Ministry of Human Resources and Social Security has announced key leadership changes within the...

Recent updates

  • China’s CDE Announces 95th Batch of Reference Preparations for Public Comment
  • China Ministry of Finance Restricts EU-Imported Medical Devices in Government Procurement Over RMB45 Million
  • SCG Cell Therapy Obtains NMPA Approval for SCG101V in Chronic HBV Study
  • BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment
  • AstraZeneca’s Imfinzi Approved in EU for Perioperative Treatment of Muscle-Invasive Bladder Cancer
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Policy / Regulatory

China’s CDE Announces 95th Batch of Reference Preparations for Public Comment

Policy / Regulatory

China Ministry of Finance Restricts EU-Imported Medical Devices in Government Procurement Over RMB45 Million

Company Drug

SCG Cell Therapy Obtains NMPA Approval for SCG101V in Chronic HBV Study

Company Medical Device

BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.